The Virus Counter® Plus enables direct and reliable virus quantification for faster decisions
The Virus Counter® Plus platform enables rapid, direct, and reliable quantification of virus particles to support faster and more confident decision-making. By delivering near-real-time titer insights, the system helps accelerate process development and optimize manufacturing workflows. Automated sample processing and an intuitive software environment ensure efficient, reproducible, and scalable virus analysis.
The platform utilizes Virotag® antibody-based reagents for biologically specific virus detection. By targeting defined viral epitopes, these reagents enable consistent and reliable particle quantification across a wide range of samples, making them an essential component of the Virus Counter® Plus system.
- Accelerate time-to-result and process development timelines with rapid titer insights
- Highly reproducible results allow critical decision-making with strong confidence
- Advanced signal detection for higher sensitivity and improved precision
Virus Counter® Plus Platform
Discover the Virus Counter® Plus Platform
Your Efficient Solution for Rapid Virus Quantification
The Virus Counter® Plus platform revolutionizes virus quantification for industry, particularly in fields such as Advanced Therapeutics , Viral Vector manufacturing and Vaccines. Customers in cell and gene therapy rely on the Virus Counter® Plus for its rapid, accurate measurement of total virus particles, unlike traditional methods that are slow and imprecise. As viruses become crucial tools in gene therapy, vaccines, and cell modifications, the Virus Counter® Plus meets the growing and evolving market demands efficiently and effectively.
Virotag® reagents enable reliable, ready-to-use virus quantification
Virotag® antibody-based reagents enable a rapid, no-wash assay workflow for efficient virus detection.
Designed for use with the Virus Counter® Plus platform, these reagents deliver biologically specific and reliable quantification of virus particles. Real-time titer insights support faster decision making and help optimize development and manufacturing processes.
Virotag® AB Reagent
Virotag® AB Reagent – The Ideal Quantification Solution
Antibody-Based Virus Detection for Direct and Reliable Particle Quantification
Virotag® AB reagents enable direct, biologically specific detection of virus particles using fluorescently labeled antibodies. By targeting defined viral epitopes, the system delivers reliable and real-time particle counts to support confident decision-making.
The antibody-based approach complements established analytical methods by providing an additional, direct measurement of total virus particles, enabling a more comprehensive understanding of viral samples.
- Direct measurement of total virus particles
- Biologically specific detection via antibody binding
- Complements established analytical workflows
- Enables faster access to decision-relevant data
- Simple no-wash workflow for efficient sample processing
Target your specific virus with highly specific antibody-based reagents
| Enveloped Virus | Virotag® AB Reagent |
|---|---|
| Enveloped Virus (universal) | |
| Baculovirus | (Virotag BCVB) |
| Influenza A | (Virotag INVA) |
| Influenza B | (Virotag INVB) |
| Lentivirus | (Virotag VSVG*) |
* for VSV-G pseudotyped Lentivirus
Learn More About Virus Quantification
Related Assets
